home / stock / selb / selb quote
Last: | $0.8812 |
---|---|
Change Percent: | 7.42% |
Open: | $0.8867 |
Close: | $0.8812 |
High: | $0.9399 |
Low: | $0.81 |
Volume: | 2,770,271 |
Last Trade Date Time: | 11/13/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.8812 | $0.8867 | $0.8812 | $0.9399 | $0.81 | 2,770,271 | 11-13-2023 |
$0.9578 | $1.01 | $0.9578 | $1.015 | $0.95 | 614,777 | 11-10-2023 |
$1 | $1.04 | $1 | $1.06 | $0.99 | 475,618 | 11-09-2023 |
$1.05 | $1.08 | $1.05 | $1.08 | $1.05 | 395,043 | 11-08-2023 |
$1.06 | $1.08 | $1.06 | $1.13 | $1.06 | 365,416 | 11-07-2023 |
$1.1 | $1.17 | $1.1 | $1.18 | $1.1 | 301,191 | 11-06-2023 |
$1.15 | $1.2 | $1.15 | $1.22 | $1.14 | 536,960 | 11-03-2023 |
$1.18 | $1.16 | $1.18 | $1.185 | $1.155 | 200,103 | 11-02-2023 |
$1.16 | $1.21 | $1.16 | $1.23 | $1.15 | 367,674 | 11-01-2023 |
$1.25 | $1.27 | $1.25 | $1.3 | $1.23 | 346,678 | 10-31-2023 |
$1.26 | $1.23 | $1.26 | $1.26 | $1.23 | 376,877 | 10-30-2023 |
$1.23 | $1.18 | $1.23 | $1.24 | $1.16 | 651,603 | 10-27-2023 |
$1.19 | $1.15 | $1.19 | $1.2 | $1.12 | 418,721 | 10-26-2023 |
$1.15 | $1.14 | $1.15 | $1.16 | $1.12 | 324,112 | 10-25-2023 |
$1.15 | $1.16 | $1.15 | $1.18 | $1.13 | 306,373 | 10-24-2023 |
$1.12 | $1.1 | $1.12 | $1.17 | $1.0872 | 504,581 | 10-23-2023 |
$1.1 | $1.12 | $1.1 | $1.14 | $1.07 | 626,302 | 10-20-2023 |
$1.12 | $1.17 | $1.12 | $1.17 | $1.1 | 630,517 | 10-19-2023 |
$1.15 | $1.18 | $1.15 | $1.23 | $1.14 | 301,295 | 10-18-2023 |
$1.21 | $1.12 | $1.21 | $1.23 | $1.12 | 644,447 | 10-17-2023 |
News, Short Squeeze, Breakout and More Instantly...
Selecta Biosciences Inc. Company Name:
SELB Stock Symbol:
NASDAQ Market:
Selecta Biosciences Inc. Website:
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta ...
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta ...
– Merger creates a fully integrated, publicly traded company pioneering RNA cell therapy for the treatment of autoimmune disease – – Cartesi...